Clinical Trial Update: Assessment Study to Evaluate Specific Immune Response in Locally Advanced Cervix Cancer After Radio-chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing specific immune response in locally advanced cervical cancer after radiochemotherapy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Snippet

Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle | Conditions: Cervical Cancer | Phase 2 | Status: TERMINATED